ID   TIG1_HUMAN              Reviewed;         294 AA.
AC   P49788; Q8N1D7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 2.
DT   07-APR-2021, entry version 149.
DE   RecName: Full=Retinoic acid receptor responder protein 1;
DE   AltName: Full=Phorbol ester-induced gene 1 protein;
DE            Short=PERG-1;
DE   AltName: Full=RAR-responsive protein TIG1;
DE   AltName: Full=Tazarotene-induced gene 1 protein;
GN   Name=RARRES1; Synonyms=PEIG1, TIG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-42.
RC   TISSUE=Skin;
RX   PubMed=8601727; DOI=10.1111/1523-1747.ep12340668;
RA   Nagpal S., Patel S., Asano A.T., Johnson A.T., Duvic M.,
RA   Chandraratna R.A.S.;
RT   "Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-
RT   responsive gene in skin.";
RL   J. Invest. Dermatol. 106:269-274(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8832110;
RA   Cafferata E.G., Gonzalez-Guerrico A.M., Pivetta O.H., Santa-Coloma T.A.;
RT   "Identification by differential display of a mRNA specifically induced by
RT   12-O-tetradecanoylphorbol-13-acetate (TPA) in T84 human colon carcinoma
RT   cells.";
RL   Cell. Mol. Biol. 42:797-804(1996).
RN   [4]
RP   FUNCTION, LACK OF GLYCOSYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=21303978; DOI=10.1158/0008-5472.can-10-2294;
RA   Sahab Z.J., Hall M.D., Me Sung Y., Dakshanamurthy S., Ji Y., Kumar D.,
RA   Byers S.W.;
RT   "Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2
RT   to regulate the alpha-tubulin tyrosination cycle.";
RL   Cancer Res. 71:1219-1228(2011).
CC   -!- FUNCTION: Inhibitor of the cytoplasmic carboxypeptidase AGBL2, may
CC       regulate the alpha-tubulin tyrosination cycle.
CC       {ECO:0000269|PubMed:21303978}.
CC   -!- INTERACTION:
CC       P49788; P20155: SPINK2; NbExp=5; IntAct=EBI-25504187, EBI-10200479;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:21303978}; Single-
CC       pass type III membrane protein {ECO:0000269|PubMed:21303978}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2;
CC         IsoId=P49788-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=P49788-2; Sequence=VSP_010697, VSP_010698;
CC   -!- INDUCTION: By tazarotene and by all the retinoic acid receptors tested.
CC   -!- PTM: Not glycosylated.
CC   -!- SIMILARITY: Belongs to the protease inhibitor I47 (latexin) family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RARRES1ID42050ch3q25.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U27185; AAA99722.1; -; mRNA.
DR   EMBL; BC029640; AAH29640.1; -; mRNA.
DR   CCDS; CCDS3184.1; -. [P49788-1]
DR   CCDS; CCDS54665.1; -. [P49788-2]
DR   RefSeq; NP_002879.2; NM_002888.3. [P49788-2]
DR   RefSeq; NP_996846.1; NM_206963.1. [P49788-1]
DR   SMR; P49788; -.
DR   BioGRID; 111853; 1.
DR   IntAct; P49788; 1.
DR   STRING; 9606.ENSP00000237696; -.
DR   DrugBank; DB00755; Tretinoin.
DR   MEROPS; I47.002; -.
DR   GlyGen; P49788; 1 site.
DR   iPTMnet; P49788; -.
DR   PhosphoSitePlus; P49788; -.
DR   BioMuta; RARRES1; -.
DR   DMDM; 57014141; -.
DR   jPOST; P49788; -.
DR   MassIVE; P49788; -.
DR   PaxDb; P49788; -.
DR   PeptideAtlas; P49788; -.
DR   PRIDE; P49788; -.
DR   ProteomicsDB; 56117; -. [P49788-1]
DR   ProteomicsDB; 56118; -. [P49788-2]
DR   TopDownProteomics; P49788-2; -. [P49788-2]
DR   Antibodypedia; 1295; 358 antibodies.
DR   DNASU; 5918; -.
DR   Ensembl; ENST00000237696; ENSP00000237696; ENSG00000118849. [P49788-1]
DR   Ensembl; ENST00000479756; ENSP00000418556; ENSG00000118849. [P49788-2]
DR   GeneID; 5918; -.
DR   KEGG; hsa:5918; -.
DR   UCSC; uc003fci.4; human. [P49788-1]
DR   CTD; 5918; -.
DR   DisGeNET; 5918; -.
DR   GeneCards; RARRES1; -.
DR   HGNC; HGNC:9867; RARRES1.
DR   HPA; ENSG00000118849; Tissue enhanced (heart muscle, vagina).
DR   MIM; 605090; gene.
DR   neXtProt; NX_P49788; -.
DR   OpenTargets; ENSG00000118849; -.
DR   PharmGKB; PA34228; -.
DR   VEuPathDB; HostDB:ENSG00000118849.9; -.
DR   eggNOG; ENOG502S0TS; Eukaryota.
DR   GeneTree; ENSGT00530000063813; -.
DR   HOGENOM; CLU_083048_1_0_1; -.
DR   InParanoid; P49788; -.
DR   OMA; MWEKTTQ; -.
DR   OrthoDB; 1129396at2759; -.
DR   PhylomeDB; P49788; -.
DR   TreeFam; TF332787; -.
DR   PathwayCommons; P49788; -.
DR   SIGNOR; P49788; -.
DR   BioGRID-ORCS; 5918; 3 hits in 987 CRISPR screens.
DR   ChiTaRS; RARRES1; human.
DR   GeneWiki; RARRES1; -.
DR   GenomeRNAi; 5918; -.
DR   Pharos; P49788; Tbio.
DR   PRO; PR:P49788; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P49788; protein.
DR   Bgee; ENSG00000118849; Expressed in pericardium and 185 other tissues.
DR   Genevisible; P49788; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0008191; F:metalloendopeptidase inhibitor activity; IBA:GO_Central.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; TAS:ProtInc.
DR   InterPro; IPR009684; Prot_inh_latexin.
DR   InterPro; IPR027261; TAG1.
DR   PANTHER; PTHR28591; PTHR28591; 1.
DR   Pfam; PF06907; Latexin; 1.
DR   PIRSF; PIRSF011132; Prot_inh_latexin; 1.
DR   PIRSF; PIRSF500784; TAG1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Membrane; Reference proteome; Signal-anchor;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..294
FT                   /note="Retinoic acid receptor responder protein 1"
FT                   /id="PRO_0000191346"
FT   TOPO_DOM        1..20
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        21..42
FT                   /note="Helical; Signal-anchor for type III membrane
FT                   protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        43..294
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         225..228
FT                   /note="KTND -> VRKT (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:8601727"
FT                   /id="VSP_010697"
FT   VAR_SEQ         229..294
FT                   /note="Missing (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:8601727"
FT                   /id="VSP_010698"
FT   VARIANT         42
FT                   /note="D -> G (in dbSNP:rs7621322)"
FT                   /evidence="ECO:0000269|PubMed:8601727"
FT                   /id="VAR_060094"
FT   VARIANT         158
FT                   /note="D -> V (in dbSNP:rs11919919)"
FT                   /id="VAR_053612"
FT   CONFLICT        62
FT                   /note="A -> K (in Ref. 1; AAA99722)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   294 AA;  33285 MW;  BDBA3E034F493032 CRC64;
     MQPRRQRLPA PWSGPRGPRP TAPLLALLLL LAPVAAPAGS GDPDDPGQPQ DAGVPRRLLQ
     QAARAALHFF NFRSGSPSAL RVLAEVQEGR AWINPKEGCK VHVVFSTERY NPESLLQEGE
     GRLGKCSARV FFKNQKPRPT INVTCTRLIE KKKRQQEDYL LYKQMKQLKN PLEIVSIPDN
     HGHIDPSLRL IWDLAFLGSS YVMWEMTTQV SHYYLAQLTS VRQWKTNDDT IDFDYTVLLH
     ELSTQEIIPC RIHLVWYPGK PLKVKYHCQE LQTPEEASGT EEGSAVVPTE LSNF
//
